Nutrition and Alzheimer’s disease: The detrimental role of a high carbohydrate diet
Abstract
Alzheimer's disease is a devastating disease whose recent increase in incidence rates has broad implications for rising health care costs. Huge amounts of research money are currently being invested in seeking the underlying cause, with corresponding progress in understanding the disease progression. In this paper, we highlight how an excess of dietary carbohydrates, particularly fructose, alongside a relative deficiency in dietary fats and cholesterol, may lead to the development of Alzheimer's disease.
A first step in the pathophysiology of the disease is represented by advanced glycation end-products in crucial plasma proteins concerned with fat, cholesterol, and oxygen transport. This leads to cholesterol deficiency in neurons, which significantly impairs their ability to function. Over time, a cascade response leads to impaired glutamate signaling, increased oxidative damage, mitochondrial and lysosomal dysfunction, increased risk to microbial infection, and, ultimately, apoptosis. Other neurodegenerative diseases share many properties with Alzheimer's disease, and may also be due in large part to this same underlying cause. © 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Stephanie Seneff , Glyn Wainwright , Luca Mascitelli
http://people.csail.mit.edu/seneff/EJIM_PUBLISHED.pdf
Other similar publications
Breakthrough in Alzheimer’s disease may lie with new research drug
Alzheimer’s disease is a neurodegenerative disorder that affects more than 5.3 million families in the United States each year and unleashes a path of emotional and financial heartache for patients and their families. Cleveland Kinney is researching an experimental drug known as bapineuzumab. UAB is participating in national and international Phase Breakthrough in Alzheimer’s disease may lie with new research drug
Physiological Markers for Alzheimer’s Disease
Martin Kurtev Alzheimer’s disease is the most common cause of intellectual decline associated with aging. This disorder involves the deterioration of mental functions resulting from changes in brain tissue, such as the shrinkage of certain brain structures. There is no known definitive cure for Alzheimer’s disease, and treatment is most Physiological Markers for Alzheimer’s Disease
Anti-inflammatory drugs reduce effectiveness of SSRI antidepressants
Scientists at Rockefeller University have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, often prescribed for depression and obsessive-compulsive and anxiety disorders. The Anti-inflammatory drugs reduce effectiveness of SSRI antidepressants
Alzheimer’s disease and Puzzles
Named for Dr. Alois Alzheimer, who first described the disease in 1907, Alzheimer's disease causes gradually increasing dementia, including memory loss, confusion, problems with judgment, planning and concentration, and personality changes; in its later stages it also affects physical abilities. The disease's causes, cures and preventions Alzheimer’s disease and Puzzles
Olanzapine Versus Divalproex in the Treatment of Acute Mania
“Olanzapine Versus Divalproex in the Treatment of Acute Mania” is a research article that was published in the June, 2002 issue of the American Journal of Psychiatry (Tohen et al., 2002). Both olanzapine and divalproex are medications that are commonly prescribed to treat bipolar disorder, which was formerly known as manic depression. Olanzapine Versus Divalproex in the Treatment of Acute Mania